Home > Insider Trading > Filing (0001178913-15-002941)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1158780	Pluristem Therapeutics Inc	PSTI	Biological Products, (No Disgnostic Substances) (2836)	980351734

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1320556	Israel Ben-Yoram	24 Barkan Street Rishon Lezion L3 75436		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2015-09-21	30,000	$2.10	176,056	No	4	S	Direct
Common Stock	Acquisiton	2015-09-21	12,300	$2.07	188,356	No	4	P	Direct
Common Stock	Acquisiton	2015-09-21	3,200	$2.08	191,556	No	4	P	Direct
Common Stock	Acquisiton	2015-09-21	100	$2.09	191,656	No	4	P	Direct
Common Stock	Acquisiton	2015-09-21	7,200	$2.10	198,856	No	4	P	Direct
Common Stock	Acquisiton	2015-09-21	3,900	$2.11	202,756	No	4	P	Direct
Common Stock	Acquisiton	2015-09-21	3,300	$2.14	206,056	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	162,750	Indirect	By Eshed Dash Ltd

Footnotes

The reporting person's sale of 30,000 shares of PSTI common stock reported herein is matchable under Section 16(b) of the Securities Exchange Act of 1934 with the reporting person's purchase of 30,000 shares of PSTI common stock reported herein. The reporting person has agreed to pay to PSTI, upon settlement of the sale, $323, representing the full amount of the profit realized in connection with the short-swing transaction.
Private sale in New Israeli Shekels (NIS) for a per share price of NIS 8.12, which per share price has been reported on this Form 4 in U.S. dollars based on an exchange rate of NIS 3.863 per U.S. dollar.